Launch and progress of the NavigAIT.me clinical study, which collects patient-reported data from people with allergies through the Caaring® digital platform
At the beginning of the year, NavigAIT.me was successfully launched, a project by the SEAIC (Spanish Society of Allergology and Clinical Immunology), coordinated by the Fundación Hospital Infantil Niño Jesús and led by Dr. Pablo Rodríguez del Río, Consultant Specialist in Allergology at the hospital.
The AI Revolution in Healthcare in 2026
Artificial Intelligence (AI) is transforming every industry, and healthcare is no exception. In 2024, we discussed the role of AI in healthcare and the potential this technology offers in research, prevention, diagnosis, and treatment. By 2026, its value and possibilities are undeniable, but the focus of the conversation has shifted.
Healthcare Innovation in Spain: From Technological Development to Real-World Integration into the Healthcare System
The Complutense University of Madrid Summer Course on biopharmaceutical innovation brought together leaders from Spain’s healthcare ecosystem. Roberto Bravo, CEO and founder of Persei vivarium by Zelenza Group, joined the roundtable “Healthcare Innovation in Action: Success Stories, Challenges and the Future.”
Persei vivarium advances an integrated solution for the continuous follow-up of oncology patients
The rising incidence of cancer, increasing healthcare system pressure, and the growing complexity of treatments are transforming cancer care delivery and creating new challenges for healthcare professionals and health systems.
The role of Digital Health in obesity management
Obesity has become one of the growing public health challenges worldwide. According to the World Health Organization (WHO), more than 1 billion people are living with obesity globally, including adults, adolescents, and children. In Spain, recent data indicate that between 17% and 23.8% of the adult population is affected by obesity.
GETECCU recognized as a national reference in Inflammatory Bowel Disease (IBD), driven by the ENEIDA registry
Recently, GETECCU has published an overview of its trajectory as the leading reference group in IBD in Spain in the journal “Therapeutic Advances in Gastroenterology”, through the article “GETECCU: a comprehensive national strategy for excellence in inflammatory bowel disease”.